KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Curent Deferred Tax Liability Current Assets Current Deferred Tax Assets Current Deferred Tax Assets Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Eli Lilly (LLY) Liabilities from Discontinued Operations (2018)

Eli Lilly filings provide 1 years of Liabilities from Discontinued Operations readings, the most recent being 2742300000.0 for Q4 2018.

On a quarterly basis, Liabilities from Discontinued Operations changed N/A to 2742300000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was 2742300000.0, a N/A change, with the full-year FY2018 number at 2742300000.0, changed N/A from a year prior.
Liabilities from Discontinued Operations hit 2742300000.0 in Q4 2018 for Eli Lilly.
In the past five years, Liabilities from Discontinued Operations ranged from a high of 2742300000.0 in Q4 2018 to a low of 2742300000.0 in Q4 2018.